A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Author(s):  
2021 ◽  
Vol 62 (5) ◽  
pp. 455-463
Author(s):  
Sandra Bašić-Kinda ◽  
Karla Mišura Jakobac ◽  
Jasminka Sinčić-Petričević ◽  
Dajana Deak ◽  
Marijo Vodanović ◽  
...  

2019 ◽  
Author(s):  
Charles Tong ◽  
Peter Papagiannopoulos ◽  
Michael Feldman ◽  
Nithin Adappa ◽  
James Palmer

2006 ◽  
Vol preprint (2007) ◽  
pp. 1
Author(s):  
Kristi Smock ◽  
Hassan Yaish ◽  
Mitchell Cairo ◽  
Mark Lones ◽  
Carlynn Willmore-Payne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document